| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Second Regular National Report on the Implementation of the Cartagena Protocol on Biosafety
Record information and status
Record ID
102473
Status
Published
Date of creation
2011-10-06 14:38 UTC (andrew.bowers@cbd.int)
Date of last update
2011-11-15 20:55 UTC (andrew.bowers@cbd.int)
Date of publication
2011-11-15 20:55 UTC (andrew.bowers@cbd.int)

Origin of report
Country
  • Seychelles
Contact officer for report
Coordinates
Ms. Mary May Jeremie
Director of Environmental Assessment & Permit Section
Department of Environment
Environmental Assessment & Permit Section, Department of Environment, Botanical Gardens, PO BOX 445
Mont Fleuri, Mahe
Seychelles
Phone:+248 4 670 500
Fax:+ 248 4 610 648
Email:m.mjeremie@env.gov.sc
Consulted stakeholders
9. Organizations/stakeholders who were consulted or participated in the preparation of this report
Seychelles Agricultural Agency
Seychelles Farmers Association
Wildlife, Trade and Conservation Section, Department of Environment
Environmental Assessment & Permit Section, Department of Environment
Consultant for Landfill and waste management
Plant Conservation Action Group
National Botanical Gardens Foundation
Landscape & Wastes Management Agency
Seychelles Fishing Authority
Seychelles Island Foundation
Crop Protection Section, Seychelles Agricultural Agency
Policy Section in Department of Natural Resources
Seychelles Fair Trading Commission
National Consumer Forum (NATCOF)
Consultant for drafting the  Animal and Plant Biosecurity Bill 2011  
Custom Department
Trade Department, Department of Finance
Seychelles Green Foundation
Seychelles National Parks Authority
Submission
10. Date of submission
2011-09-30
11. Time period covered by this report
Start date
2007-09
Time period covered by this report
End date
2011-09
Party to the Cartagena Protocol on Biosafety
12. Is your country a Party to the Cartagena Protocol on Biosafety (CPB)?
  • Yes
Article 2 – General provisions
15. Has your country introduced the necessary legal, administrative and other measures for the implementation of the Protocol?
  • Only temporary measures have been introduced
16. Which specific instruments are in place for the implementation of your national biosafety framework?
  • One or more sets of biosafety guidelines
  • Other laws, regulations or guidelines that indirectly apply to biosafety
17. Has your country established a mechanism for the budgetary allocations of funds for the operation of its national biosafety framework?
  • No
18. Does your country have permanent staff to administer functions directly related to the national biosafety framework?
  • No
20. Has your country’s biosafety framework / laws / regulations / guidelines been submitted to the Biosafety Clearing-House (BCH)?
  • Partially
21. Here you may provide further details on the implementation of Article 2 in your country:
Seychelles has completed its National Biosafety Framework   The 83-pages document is available on the BCH and contains Seychelles' policy on importation of GMOs, an administrative system to address GMO, Risk assessement and risk management systems, Public Awareness, education as well as Monitoring and enforcement measures.       To date Seychelles has not been able to complete the drafting of its Biosafety Law , mainly due to a lack of technical and financial capacity. Seychelles has also recently implemented a rigid macro-economic reform programme which has forced the government to re-prioritise  its functions with a much smaller workforce. The drafting of legislations related to the Macro-economic reform programme has taken precedence on other legal matters in the Attorney General's Office.   However, various provisions of the Cartagena Protocol are being gradually addressed under various laws such as; The Consumer Protection Act 2010 Biosafety has been address under 22 (10) requires all products containing genetically modified ingredients to be labelled appropriately.       Seychelles is in the process of validating its Animal and Plant Biosecurity Bill, 2011. It is a comprehensive set of laws which addresses the importation of animal and plants and their products, this includes LMOs.  A rigorous risks assessment and risk management process exist under the proposed law, but however, the administrative systems is not fully Cartagena Protocol compliant.  The Animal and Plant Biosecurity Bill is in the processs to be approved by the parliament. The Customs Management Act 2010 has all the necessary and relevant provisions for effective border control enforcement including any regulated products.
Article 5 – Pharmaceuticals
22. Does your country regulate the transboundary movement, handling and use of living modified organisms (LMOs) which are pharmaceuticals?
  • Yes, to some extent
23. If you answered Yes to question 22, has this information been submitted to the BCH?
  • Partially
24. Here you may provide further details on the implementation of Article 5 in your country:
Seychelles Health Authority has a policy with regards to imported drugs.  Seychelles Health Authority only authorise the use of drugs that have  been approved and certified by WHO and FDA (this include LMOs and their related products).  This information is available in the National Biosafety Framework which is available on the BCH.
Article 6 – Transit and Contained use
25. Does your country regulate the transit of LMOs?
  • Yes
26. Does your country regulate the contained use of LMOs?
  • Yes
27. If you answered Yes to questions 25 or 26, has this information been submitted to the BCH?
  • Partially
28. Here you may provide further details on the implementation of Article 6 in your country:
The National Biosafety Framework covers GMOs in transit and for Contained used.  There are proposed laws being developped to address both transit and Contained use LMOs in the proposed Plant and Animal Biosecurity Bill 2011. Such information is yet to be published on the BCH after approval of the Law by the Parliament.
Articles 7 to 10 – Advance Informed Agreement (AIA) and intentional introduction of LMOs into the environment
29. Has your country adopted law(s) / regulations / administrative measures for the operation of the AIA procedure of the Protocol?
  • Yes
30. Has your country adopted a domestic regulatory framework consistent with the Protocol regarding the transboundary movement of LMOs for intentional introduction into the environment?
  • No
31. Has your country established a mechanism for taking decisions regarding first intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
33. Has your country established a mechanism for monitoring potential effects of LMOs that are released into the environment?
  • No
34. Does your country have the capacity to detect and identify LMOs?
  • No
35. Has your country established legal requirements for exporters under its jurisdiction to notify in writing the competent national authority of the Party of import prior to the intentional transboundary movement of an LMO that falls within the scope of the AIA procedure?
  • No
36. Has your country established legal requirements for the accuracy of information contained in the notification?
  • No
37. Has your country ever received an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
38. Has your country ever taken a decision on an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
41. In the current reporting period, how many applications/notifications has your country received regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
42. In the current reporting period, how many decisions has your country taken regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
50. Here you may provide further details on the implementation of Articles 7-10 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs for intentional introduction to the environment:
Although the National Biosafety Framework document provides detailed guidance on the setting up of a relevant administrative system to handle AIA procedure, with the recent Macro-economic reform that Seychelles undertook has not made it possible for Seychelles to put in operation such administrative system and measures based on fiancial and human resource constraints.
Article 11 – Procedure for living modified organisms intended for direct use as food or feed, or for processing (LMOs-FFP)
51. Has your country adopted specific law(s) or regulation(s) for decision-making regarding domestic use, including placing on the market, of LMOs-FFP?
  • No
52. Has your country established legal requirements for the accuracy of information to be provided by the applicant?
  • No
53. Has your country established a mechanism to ensure that decisions regarding LMOs-FFP that may be subject to transboundary movement will be communicated to the Parties through the BCH?
  • Yes
54. Has your country established a mechanism for taking decisions on the import of LMOs-FFP?
  • Yes
55. Has your country declared through the BCH that in the absence of a regulatory framework its decisions prior to the first import of an LMO-FFP will be taken according to Article 11.6 of the Cartagena Protocol on Biosafety?
  • Yes
56. Has your country indicated its needs for financial and technical assistance and capacity building in respect of LMOs-FFP?
  • Yes
57. Has your country ever taken a decision on LMOs-FFP (either on import or domestic use)?
  • No
63. Here you may provide further details on the implementation of Article 11 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs-FFP:
The National Biosafety framework makes provision for LMOs-FFP, but the administrative system is not yet in operational.  In the meantime there is a moratorium on such imports/exports until the Animal and Plant Biosecurity Act is enacted.
Article 12 – Review of decision
64. Has your country established a mechanism for the review and change of a decision regarding an intentional transboundary movement of LMOs?
  • No
65. Has your country ever received a request for a review of a decision?
  • No
66. Has your country ever reviewed / changed a decision regarding an intentional transboundary movement of LMOs?
  • No
67. In the current reporting period, how many decisions were reviewed and/or changed regarding an intentional transboundary movement of an LMO?
  • None
71. Here you may provide further details on the implementation of Article 12 in your country:
The Administrative system is not yet in place to facilitate decision making, but progress is being made to request for capacity building assistance in order to comply with Article 12
Article 13 – Simplified procedure
72. Has your country established a system for the application of the simplified procedure regarding an intentional transboundary movement of LMOs?
  • Yes
73. Has your country ever applied the simplified procedure?
  • No
75. In the current reporting period, how many LMOs has your country applied the simplified procedure to?
  • None
76. Here you may provide further details on the implementation of Article 13 in your country:
Again, due to the lack of approriate administrative system, it has not been possible for Article 13 to be implemented, although it is clearly addressed in the NBF
Article 14 – Bilateral, regional and multilateral agreements and arrangements
77. Has your country entered into any bilateral, regional or multilateral agreements or arrangements?
  • No
Article 15 – Risk assessment
81. Has your country established a mechanism for conducting risk assessments prior to taking decisions regarding LMOs?
  • No
83. Has your country established guidelines for how to conduct risk assessments prior to taking decisions regarding LMOs?
  • No
84. Has your country acquired the necessary domestic capacity to conduct risk assessment?
  • No
85. Has your country established a mechanism for training national experts to conduct risk assessments?
  • No
86. Has your country ever conducted a risk assessment of an LMO for intentional introduction into the environment?
  • No
87. Has your country ever conducted a risk assessment of an LMO intended for direct use as food or feed, or for processing?
  • No
88. If your country has taken decision(s) on LMOs for intentional introduction into the environment or on domestic use of LMOs-FFP, were risk assessments conducted for all decisions taken?
  • Not applicable
89. Has your country submitted summary reports of the risk assessments to the BCH?
  • Not applicable
90. In the current reporting period, if your country has taken decisions regarding LMOs, how many risk assessments were conducted in the context of these decisions?
  • None
91. Has your country ever required the exporter to conduct the risk assessment(s)?
  • Not applicable
92. Has your country ever required the notifier to bear the cost of the risk assessment(s) of LMOs?
  • Not applicable
93. Here you may provide further details on the implementation of Article 15 in your country:
Article 15 is one area whereby Seychelles have a severe lack of insitutional and technical capacity (including relevant expertise)  to conduct and review risk assessment.  Although, the issue of risk assessment is addressed thoroughly in the proposed Animal and Plant Biosecurity Bill 2011, technical and institutional supports are prerequisite to the effective implementation of risk assessment
Article 16 – Risk management
94. Has your country established and maintained appropriate and operational mechanisms, measures and strategies to regulate, manage and control risks identified in risk assessments for:
94.1) LMOs for intentional introduction into the environment?
  • Yes, to some extent
94.2) LMOs intended for direct use as food or feed, or for processing?
  • Yes, to some extent
95. Has your country established and maintained appropriate measures to prevent unintentional transboundary movements of LMOs?
  • Yes, to some extent
96. Has your country taken measures to ensure that any LMO, whether imported or locally developed, undergoes an appropriate period of observation that is commensurate with its life-cycle or generation time before it is put to its intended use?
  • No
97. Has your country cooperated with other Parties with a view to identifying LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • No
98. Has your country cooperated with other Parties with a view to taking measures regarding the treatment of LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • No
99. Here you may provide further details on the implementation of Article 16 in your country, including any details regarding risk management strategies, also in case of lack of scientific certainty on potential adverse effects of LMOs:
Until the relevant capacity building is conducted in the field of risk assessment, the NBF has imposed a moratorium on all LMOs importation, except in the Health sector (as long as it has been approved by WHO and FDA).
Article 17 – Unintentional transboundary movements and emergency measures
100. Has your country made available to the BCH the relevant details setting out its point of contact for the purposes of receiving notifications under Article 17?
  • No
101. Has your country established a mechanism for addressing emergency measures in case of unintentional transboundary movements of LMOs that are likely to have significant adverse effect on biological diversity?
  • No
102. Has your country implemented emergency measures in response to information about releases that led, or may have led, to unintentional transboundary movements of LMOs?
  • No
103. In the current reporting period, how many times has your country received information concerning occurrences that led, or may have led, to unintentional transboundary movement(s) of one or more LMOs to or from territories under its jurisdiction?
  • Never
107. Here you may provide further details on the implementation of Article 17 in your country:
The issue of emergency measures is being addressed lengthily in the proposed Animal and Plant Biosecurity Bill 2011.
Article 18 – Handling, transport, packaging and identification
108. Has your country taken measures to require that LMOs that are subject to transboundary movement are handled, packaged and transported under conditions of safety, taking into account relevant international rules and standards?
  • Yes, to some extent
109. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is not known through means such as identity preservation systems, they may contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • No
110. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is known through means such as identity preservation systems, they contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • No
111. Has your country taken measures to require that documentation accompanying LMOs that are destined for contained use clearly identifies them as living modified organisms and specifies any requirements for the safe handling, storage, transport and use, the contact point for further information, including the name and address of the individual and institution to whom the LMO are consigned?
  • No
112. Has your country taken measures to require that documentation accompanying LMOs that are intended for intentional introduction into the environment of the Party of import, clearly identifies them as living modified organisms; specifies the identity and relevant traits and/or characteristics, any requirements for the safe handling, storage, transport and use, the contact point for further information and, as appropriate, the name and address of the importer and exporter; and contains a declaration that the movement is in conformity with the requirements of this Protocol applicable to the exporter?
  • Yes, to some extent
113. Does your country have the capacity to enforce the requirements of identification and documentation of LMOs?
  • Yes, to some extent
114. Has your country established procedures for the sampling and detection of LMOs?
  • No
115. Here you may provide further details on the implementation of Article 18 in your country:
The only implementation of Article 18 being implemented is the labelling of products containing GMOs in the Consumer protection Act 2010
Article 19 – Competent National Authorities and National Focal Points
116. Has your country designated one national focal point for the Cartagena Protocol to be responsible for liaison with the Secretariat?
  • Yes
117. Has your country designated one national focal point for the Biosafety Clearing-House to liaise with the Secretariat regarding issues of relevance to the development and implementation of the BCH?
  • Yes
118. Has your country designated one or more competent national authorities, which are responsible for performing the administrative functions required by the Cartagena Protocol on Biosafety and are authorized to act on your country’s behalf with respect to those functions?
  • Yes, one
120. Has your country made available the required information referred in questions 116-119 to the BCH?
  • Yes, all information
122. Has your country established adequate institutional capacity to enable the competent national authority(ies) to perform the administrative functions required by the Cartagena Protocol on Biosafety?
  • Yes, to some extent
123. Here you may provide further details on the implementation of Article 19 in your country:
More training is required expecially in the field of risk assessment and risk management.                                           ]
Article 20 – Information Sharing and the Biosafety Clearing-House (BCH)
124. Please provide an overview of the status of the information provided by your country to the BCH by specifying for each category of information whether it is available and whether it has been submitted to the BCH.
124.a) Existing national legislation, regulations and guidelines for implementing the Protocol, as well as information required by Parties for the advance informed agreement procedure (Article 20, paragraph 3 (a))
  • Information available but only partially available in the BCH
124.b) National laws, regulations and guidelines applicable to the import of LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 5)
  • Information available but only partially available in the BCH
124.c) Bilateral, multilateral and regional agreements and arrangements (Articles 14, paragraph 2 and 20, paragraph 3 (b))
  • Information not available
124.d) Contact details for competent national authorities (Article 19, paragraphs 2 and 3), national focal points (Article 19, paragraphs 1 and 3), and emergency contacts (Article 17, paragraph 3 (e))
  • Information available and in the BCH
124.e) Reports submitted by the Parties on the operation of the Protocol (Article 20, paragraph 3 (e))
  • Information available and in the BCH
124.f) Decisions by a Party on regulating the transit of specific living modified organisms (LMOs) (Article 6, paragraph 1)
  • Information not available
124.g) Occurrence of unintentional transboundary movements that are likely to have significant adverse effects on biological diversity (Article 17, paragraph 1)
  • Information not available
124.h) Illegal transboundary movements of LMOs (Article 25, paragraph 3)
  • Information not available
124.i) Final decisions regarding the importation or release of LMOs (i.e. approval or prohibition, any conditions, requests for further information, extensions granted, reasons for decision) (Articles 10, paragraph 3 and 20, paragraph 3(d))
  • Information not available
124.j) Information on the application of domestic regulations to specific imports of LMOs (Article 14, paragraph 4)
  • Information not available
124.k) Final decisions regarding the domestic use of LMOs that may be subject to transboundary movement for direct use as food or feed, or for processing (Article 11, paragraph 1)
  • Information not available
124.l) Final decisions regarding the import of LMOs intended for direct use as food or feed, or for processing that are taken under domestic regulatory frameworks (Article 11, paragraph 4) or in accordance with annex III (Article 11, paragraph 6) (requirement of Article 20, paragraph 3(d))
  • Information not available
124.m) Declarations regarding the framework to be used for LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 6)
  • Information not available
124.n) Review and change of decisions regarding intentional transboundary movements of LMOs (Article 12, paragraph 1)
  • Information not available
124.o) LMOs granted exemption status by each Party (Article 13, paragraph 1)
  • Information not available
124.p) Cases where intentional transboundary movement may take place at the same time as the movement is notified to the Party of import (Article 13, paragraph 1)
  • Information not available
124.q) Summaries of risk assessments or environmental reviews of LMOs generated by regulatory processes and relevant information regarding products thereof (Article 20, paragraph 3 (c))
  • Information not available
125. Has your country established a mechanism for strengthening the capacity of the BCH National Focal Point to perform its administrative functions?
  • Yes
126. Has your country established a mechanism for the coordination among the BCH National Focal Point, the Cartagena Protocol focal point, and the competent national authority(ies) for making information available to the BCH?
  • Yes
127. Does your country use the information available in the BCH in its decision making processes on LMOs?
  • No
128. Has your country experienced difficulties accessing or using the BCH?
  • No
129. If you answered Yes to question 128, has your country reported these problems to the BCH or the Secretariat?
  • Not applicable
130. Is the information submitted by your country to the BCH complete and up-to date?
  • No
131. Here you may provide further details on the implementation of Article 20 in your country:
Information is being updated as and when is available digitally
Article 21 – Confidential information
132. Has your country established procedures to protect confidential information received under the Protocol?
  • Yes
133. Does your country allow the notifier to identify information that is to be treated as confidential?
  • No
134. Here you may provide further details on the implementation of Article 21 in your country:
So far Seychelles has not access confidential information in the field of Biosafety, but there are sufficient administrative provisions within most laws to address the issue of confidential information.
Article 22 – Capacity-building
135. Has your country received external support or benefited from collaborative activities with other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
136. If you answered Yes to question 135, how were these resources made available?
  • Multilateral channels
137. Has your country provided support to other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • No
139. Is your country eligible to receive funding from the Global Environment Facility (GEF)?
  • Yes
140. Has your country ever initiated a process to access GEF funds for building capacity in biosafety?
  • No
142. Has your country ever received funding from the GEF for building capacity in biosafety?
  • Development of national biosafety frameworks
  • Building Capacity for Effective Participation in the BCH (Phase I)
143. During the current reporting period, has your country undertaken activities for the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
144. If you answered Yes to question 143, in which of the following areas were these activities undertaken?
  • Identification of LMOs, including their detection
  • Scientific biosafety research relating to LMOs
145. During the current reporting period, has your country carried out a capacity-building needs assessment?
  • No
146. Does your country still have capacity-building needs?
  • Yes
147. If you answered Yes to question 146, indicate which of the following areas still need capacity-building.
  • Institutional capacity
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Public awareness, participation and education in biosafety
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Scientific, technical and institutional collaboration at subregional, regional and international levels
  • Technology transfer
  • Identification of LMOs, including their detection
  • Socio-economic considerations
  • Implementation of the documentation requirements under Article 18.2 of the Protocol
  • Handling of confidential information
  • Measures to address unintentional and/or illegal transboundary movements of LMOs
  • Taking into account risks to human health
148. Has your country developed a capacity-building strategy or action plan?
  • No
149. Has your country submitted the details of national biosafety experts to the Roster of Experts in the BCH?
  • Yes
150. Here you may provide further details on the implementation of Article 22 in your country, including further details about your experience in accessing GEF funds:
Roster of expert has been submitted as per of the NBF
Article 23 – Public awareness and participation
151. Has your country established a strategy or put in place legislation for promoting and facilitating public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes, to some extent
152. Has your country established a biosafety website?
  • No
153. Has your country established a mechanism to ensure public access to information on living modified organisms that may be imported?
  • No
154. Has your country established a mechanism to consult the public in the decision-making process regarding LMOs?
  • No
155. Has your country established a mechanism to make available to the public the results of decisions taken on LMOs?
  • Yes, to a limited extent
157. In the current reporting period, has your country promoted and facilitated public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes, to a limited extent
158. If you answered Yes to question 157, has your country cooperated with other States and international bodies?
  • No
159. In the current reporting period, how many times has your country consulted the public in the decision-making process regarding LMOs and made the results of such decisions available to the public?
  • None
Article 24 – Non-Parties
161. Has your country entered into any bilateral, regional, or multilateral agreement with non-Parties regarding transboundary movements of LMOs?
  • No
162. Has your country ever imported LMOs from a non-Party?
  • No
163. Has your country ever exported LMOs to a non-Party?
  • No
166. If your country is not a Party to the Cartagena Protocol, has it contributed information to the BCH on LMOs released in, or moved into, or out of, areas within its national jurisdiction?
  • Not applicable
Article 25 – Illegal transboundary movements
168. Has your country adopted domestic measures aimed at preventing and/or penalizing transboundary movements of LMOs carried out in contravention of its domestic measures to implement this Protocol?
  • No
169. Has your country established a strategy for detecting illegal transboundary movements of LMOs?
  • No
170. In the current reporting period, how many times has your country received information concerning cases of illegal transboundary movements of an LMO to or from territories under its jurisdiction?
  • Never
Article 26 – Socio-economic considerations
176. If your country has taken a decision on import, has it ever taken into account socio-economic considerations arising from the impact of the LMO on the conservation and sustainable use of biological diversity?
  • Not applicable
177. Has your country cooperated with other Parties on research and information exchange on any socio-economic impacts of LMOs?
  • No
Article 27 – Liability and Redress
179. Has your country signed the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress?
  • No
180. Has your country initiated steps towards ratification, acceptance or approval of the Nagoya-Kuala Lumpur Supplementary Protocol?
  • Yes
181. Here you may provide further details on any activities undertaken in your country towards the implementation of the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress:
Seychelles has initiated the process of implementation of the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress
Article 33 – Monitoring and reporting
182. Has your country submitted the previous national reports (Interim and First National Reports)?
  • Yes
183. If your country did not submit previous reports, indicate the main challenges that hindered the submission
  • Not applicable
Other information
184. Please use this field to provide any other information on issues related to national implementation of the Protocol, including any obstacles or impediments encountered.
Seychelles requires a lot of assistance with bilateral, regional and multinational partners in order to fully implement the provisions of the protocol. At the moment Seychelles does not have the financial capacity to address a number of provisions under the protocol.

Re: Q. 15 - Only a draft framework exists
Comments on reporting format
185. Please use this field to provide any other information on difficulties that you have encountered in filling in this report.
In some rare cases people are relectant to provide information about their trading partners (especially in commodity imports)
Survey on indicators of the Strategic Plan (2014)
In decision BS-VI/15, Parties requested the Executive Secretary to conduct a dedicated survey to gather information corresponding to indicators in the Strategic Plan that could not be obtained from the second national reports or through other existing mechanisms.

The answers to the survey are displayed below.
When did your national biosafety framework become operational?
indicator 1.1.1
  • 2005
Here you may provide further details
This has been mostly in the form of co-financing in the UNEP-GEF projects that we have been involved with over the past four years
Survey 4. How many biosafety short-term training programmes and/or academic courses are offered annually in your country?
indicator 1.2.3
  • None
Here you may provide further details
During the time that the BCH projects were running (phases 1 and 2) we had regular workshops with local personnel and people that we had earmarked as essential partners for biosafety issues. the last short term training course was held in November 2011.
Survey 5. Does your country have in place a functional national mechanism for coordinating biosafety capacity-building initiatives?
indicator 1.2.4
  • No
Here you may provide further details
Currently the national focal point sits within the Ministry of environment energy and focal point is just one of her many duties. Some aspects of biosafety are being taken up by the Seychelles Agricultural Agency together with biosecurity.
Survey 6. How much additional funding (in the equivalent of US dollars) has your country mobilized in the last four years to support implementation of the Biosafety Protocol, beyond the regular national budgetary allocation?
indicator 1.2.5
  • 5,000 USD or more
Survey 7. Does your country have predictable and reliable funding for building capacity for the effective implementation of the Protocol?
indicator 1.2.6
  • No
Here you may provide further details
At the moment there is no specific allocation for biosafety in the country
Survey 8. How many LMO-related collaborative bilateral/multilateral arrangements has your country established with other Parties/non-Parties?
indicator 1.2.8
  • None
Survey 9. Has your country adopted or used any guidance documents for the purpose of conducting risk assessment and/or risk management?
indicator 1.3.1.1
Survey 9.a) Risk assessment
  • Yes
Survey 9.b) Risk management
  • No
Here you may provide further details
The "Risk Assessment of Living Modified Organisms- Training Manual"  developed by the secretariat
Survey 10. Has your country adopted or used any guidance documents for the purpose of evaluating risk assessment reports submitted by notifiers?
indicator 1.3.1.2
  • No
Here you may provide further details
The country is yet to evaluate any risk assessment report.
Survey 11. Has your country adopted any common approaches to risk assessment with other countries?
indicator 1.3.2
  • No
Survey 12. Has your country ever conducted a risk assessment of an LMO?
indicator 1.3.3
  • No
Here you may provide further details
During the preparation of the National Biosafety Framework the team identified the different agencies/bodies that has the capacity to identify, assess and monitor living modified organisms namely under the Ministry Of Environment, the Public Health Laboratory, the Seychelles Bureau of Standards, the Veterinary services, the Plant Protection Agency. Together these agencies collectively gives us the ability to address LMO issues in biodiversity conservation, sustainable use, food safety as well as human health.    The only issue currently is that there has not been any recent inventories to check the current status and abilities of these agencies.
Survey 13. Does your country have the capacity to identify, assess and/or monitor living modified organisms or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity, taking into account risks to human health?
indicator 1.4.2
Survey 13.a) Identify
  • Yes
Survey 13.b) Assess
  • Yes
Survey 13.c) Monitor
  • Yes
Here you may provide further details
During the preparation of the National Biosafety Framework the team identified the different agencies/bodies that has the capacity to identify, assess and monitor living modified organisms namely under the Ministry Of Environment, the Public Health Laboratory, the Seychelles Bureau of Standards, the Veterinary services, the Plant Protection Agency. Together these agencies collectively gives us the ability to address LMO issues in biodiversity conservation, sustainable use, food safety as well as human health.    The only issue currently is that there has not been any recent inventories to check the current status and abilities of these agencies.
Survey 14. Does your country have available any guidance for the purpose of ensuring the safe handling, transport, and packaging of living modified organisms?
indicator 1.6.4
  • Yes
Here you may provide further details
In parts through our Biosecurity Policy
Survey 15. Does your country have any specific approaches or requirements that facilitate how socio-economic considerations should be taken into account in LMO decision making?
indicator 1.7.2
  • Yes
Here you may provide further details
Several approaches have been proposed in the National Biosafety Framework
Survey 16. How many peer-reviewed published materials has your country used for the purpose of elaborating or determining national actions with regard to socio-economic considerations?
indicator 1.7.1
  • None
Survey 17. What is your country's experience, if any, in taking socio-economic considerations into account in LMO decision making?
indicator 1.7.3
The country does not have any real experience on LMO decision making
Survey 18. Does your country have the capacity to take appropriate measures in the event that an LMO is unintentionally released?
indicator 1.8.3
  • Yes
Here you may provide further details
In parts. We will have the capacity to undertake assessments on the LMO with its associated risks, but we may struggle with redress.
Survey 19. How many people in your country have been trained in risk assessment, monitoring, management and control of LMOs?
indicator 2.2.3
Survey 19.a) Risk assessment
  • One or more
Survey 19.b) Monitoring
  • 10 or more
Survey 19.c) Management / Control
  • 10 or more
Survey 20. Does your country have the infrastructure (e.g. laboratory facilities) for monitoring or managing LMOs?
indicator 2.2.4
  • Yes
Here you may provide further details
We do not have a research facility that is dedicated only for monitoring and managing of LMOs however there are in country few recognised laboratories and organisation that can assist in identification and monitoring of LMOS for instance if necessary.     Department of Finance (Customs Division) - monitoring of commodity imports  and exports, verifying permits and certificates at the ports of entry/exit.  2. Department of Environment - monitoring GMOs in the field as field trials, research  and commercial propagation.  3. Department of Health (Division of Community Health) - monitoring food safety  standards, labeling requirements, use of GMOs and laboratory testing.  4. Seychelles Agricultural Agency (Plant Protection Section) - monitoring GMOs  in the field of Agriculture as field trials, research or commercial release, verifying  permits and certificates at the ports of entry for plants and plant products.  5. Department of Natural Resources (Veterinary Section) - monitoring GMOs in the  livestock segment of Agriculture, verifying permits and certificate at the port of entry  and conduct fish inspection.  6. Seychelles Bureau of Standard - monitoring food standards, research documents as  well as verifying laboratory standards (Reference laboratory).  7. Department of Finance (Consumer Protection Section) - monitor GMOs and  GMO products in the country with the aim of ensuring consumer protection,  inspecting goods to ensure compliance with labelling requirements as per the  Biosafety Act. Monitoring public awareness and public participation systems and  programmes to ensure compliance with the Biosafety Act, the National Consumer  Act, the National Biosafety Framework and the Cartagena Protocol for Biosafety.
Survey 21. Is your country using training material and/or technical guidance for training in risk assessment and risk management of LMOs?
indicator 2.2.5
  • Yes
Here you may provide further details
Materials available have been incorporated in the previous local workshops that have been undertaken with stakeholders, partners, etc...
Survey 22. Are the available training materials and technical guidance on risk assessment and risk management of LMOs sufficient and effective?
indicator 2.2.6
Survey 22.a) Sufficient
  • No
Survey 22.b) Effective
  • Yes
Here you may provide further details
The online training manuals are effective yes, but not sufficient for participants to become fully conversant and become able to carry out risk assessments especially given that we do not have the set up of any confined or field trials whereby we can get the opportunity to put into practise the things that are being learnt in the training materials.
Survey 23. How many customs officers in your country have received training in the identification of LMOs?
indicator 2.3.1
  • One or more
Survey 24. How many laboratory personnel in your country have received training in detection of LMOs?
indicator 2.3.1
  • One or more
Survey 25. Does your country have reliable access to laboratory facilities for the detection of LMOs?
indicator 2.3.2
  • No
Survey 26. How many laboratories in your country are certified for LMO detection?
indicator 2.3.3
  • None
Survey 27. How many of the certified laboratories in the previous question are operational?
indicator 2.3.4
  • None
Survey 28. Has your country received any financial and/or technical assistance for capacity-building in the area of liability and redress relating to living modified organisms?
indicator 2.4.1
  • Yes
Here you may provide further details
Mostly technical assistance. One or two personels have had some exposure through few workshops on liability and redress, mostly through workshops that have been held for the Nagoya-Kuala Lumpur Supplementary Protocol on liability and redress.
Survey 29. Does your country have administrative or legal instrument that provide for response measures for damage to biodiversity resulting from living modified organisms?
indicator 2.4.2
  • Yes
Here you may provide further details
The country does not currently have an act or regulations for Biosafety, however in the existing legislation there are few aspects that are covered in the  existing Environment Protection Act 1994     The Environment Protection Act 1994 formulates policies and programmes pursuance to the  national objectives on Environment protection. This Act is administered by the Department of  Environment in the Ministry of Environment and Energy. The Act makes provision to  co-ordinate the activities of other agencies concerned with the protection of the Environment. It  evolves standards for quality of the environment in its various aspects, as well as for emission or  discharge of environmental pollutants from various sources. This Act also commission research  and studies on problems relating to environmental pollution. Provisions are made under the  EPA for examining manufacturing processes, materials and substances that are likely to cause  environmental pollution and/or degradation.   The EPA also evolves procedures and safeguards for the prevention of  accidents which may cause environmental pollution, remedial measures for such accidents as  well as coordinating actions required in a state of environmental emergency or any situation  which may pose a serious threat to the environment. This Act also makes provision to collect  and disseminate information in respect of matters relating to environmental protection. No  provision has been made under this ACT for LMOs per say, but a number of sections make  adequate general provisions to tackle any adverse environmental consequences LMOs may  cause to the our natural environment.
Survey 30. Has your country informed the public about existing modalities for public participation in the decision-making process regarding living modified organisms?
indicator 2.5.2
  • Yes
Here you may provide further details
During the preparation of the National Biosafety Framework a significant amount of pulic awareness programs  were undertaken. Recently awareness raising was done with staff of the Ministry of Environment, as well as with teachers and head of schools in our attempt to have LMO issues and programs incorporated in school curriculum.
Survey 31. If you answered yes to the previous question, please indicate the modalities used to inform the public?
indicator 2.5.2
  • Newspaper
  • Forums
  • Public hearings
  • as mentioned in question 30 above
Survey 32. If you indicated multiple modalities for public participation in the question above, which one was most used?
indicator 2.5.2
  • Forums
Here you may provide further details
Focus group approach, this is because we always find it more effective when the materials that are being delivered are tailored according to the audience.
Survey 33. How many academic institutions in your country are offering biosafety education and training courses and programmes?
indicator 2.7.1
  • None
Here you may provide further details
At the moment none, but it has been proposed that biotechnology becomes an integral component of the new BSc Environmental Science (with specialisation) degree at the University of Seychelles
Survey 34. How many biosafety training materials and/or online modules are available in your country?
indicator 2.7.2
  • None
Survey 35. Does your country have in place a monitoring and/or an enforcement system?
indicator 3.1.6
Survey 35.a) Monitoring system
  • No
Survey 35.b) Enforcement system
  • No
Survey 36. Please indicate the number of regional, national and international events organized in relation to biosafety (e.g. seminars, workshops, press conferences, educational events, etc.,) in the last 2 years.
indicator 4.3.1
  • One or more
Here you may provide further details
A minimum of one workshop per year
Survey 37. Please indicate the number of biosafety related publications that has been made available in your country in the last year.
indicator 4.3.2
  • None
Survey 38. If biosafety related publications were made available (see question above), please indicate which modalities were preferred.
indicator 4.3.2
  • N/A
Survey 39. How many collaborative initiatives (including joint activities) on the Cartagena Protocol and other Conventions and processes has your government established in the last 4 years?
indicator 5.2.1
  • None
Survey 40. Does your country have any awareness and outreach programmes on biosafety?
indicator 5.3.1
  • No
Here you may provide further details
We do not have an outreach programme specifically for Biosafety. Many times biosafety will be mentioned in awareness programmes that are being made for the Convention of Biological Diversity, or other conventions and processes.
Survey 41. If you answered yes to the question above, please indicate what entity is responsible for carrying out the programmes and/or services and at which level the programmes take place.
indicator 5.3.1
E.g. local, national, etc.,
For local programs the Ministry of Environment and Energy has a Public Education Unit who prepares outreach materials with the assistance of local media.
Survey 42. Has your country designed and/or implemented an outreach/communication strategy on biosafety?
indicator 5.3.2
  • No
Survey 43. Please indicate the number of educational materials on biosafety that are available and accessible to the public.
indicator 5.3.4
  • None